Should Our Genes Be Part of the Patent Bargain? Maximizing Access to Medical Diagnostic Advances While Ensuring Research Remains Profitable

By Jacob, Johanna | Santa Clara Computer & High Technology Law Journal, January 2012 | Go to article overview

Should Our Genes Be Part of the Patent Bargain? Maximizing Access to Medical Diagnostic Advances While Ensuring Research Remains Profitable


Jacob, Johanna, Santa Clara Computer & High Technology Law Journal


I. INTRODUCTION

The purpose of the United States patent system is "[t]o promote the Progress of Science and useful Arts." (1) Currently, there is a heated emotional debate about whether patents directed to genetic sequences promote or hinder the progress of science, a debate which may soon find its way to the United States Supreme Court. (2) Unfortunately, the debate is too often characterized in terms of policy concerns. In Association for Molecular Pathology v. United States Patent and Trademark Office, Judge Sweet broke with three decades of United States Patent and Trademark Office (USPTO) precedent, (3) declaring the method and system claims to the genetic sequences of BRCA1 and BRCA2 ineligible for patents. (4) Judge Sweet created a blanket exception to 35 U.S.C. [section] 101 by characterizing genes under the "law of nature" exception to patentability. (5) Myriad Genetics Inc. (Myriad) appealed, and the Federal Circuit Court of Appeals ruled on July 29, 2011. (6) The Federal Circuit reversed Judge Sweet's ruling by upholding claims directed to isolated genetic sequences as subject matter eligible for patenting under 35 U.S.C. [section] 101. (7) However, the Federal Circuit invalidated diagnostic method claims that merely compared a genetic sequence to an individual's native genetic sequence as an abstract mental process. (8) Both parties filed a petition for rehearing in the Federal Circuit. (9)

The real issue in Association for Molecular Pathology is patient access to health care, which should not be achieved through a judicially-created exception to the statutory definition of patent eligible subject matter. While the Federal Circuit focuses on the science, the underlying issues largely guide their interpretation. It is unlikely that agreement on the science and how it applies to patent eligible subject matter will ever be achieved. Judge Moore, in his concurring opinion, rightly states that it is the policy that tips the scales towards patentability. (10)

Weakening biotechnology patent law by declaring claims to genetic sequences patent ineligible, as products of nature under 35 U.S.C. [section] 101, would negatively impact patient access to biotechnology advances by decreasing the incentive of investors to enter the market more than it could possibly help promote patient access to BRCA1 and BRCA2 diagnostic technologies. Patient access to second opinions, affordable diagnostic technologies, patient counseling, comprehensive genetic testing, and insurance coverage are not aspects of patent law, and are best addressed through meaningful health care reform.

II. Background

A. 35 U.S.C. [section] 101 Patentable Subject Matter

Patentable subject matter, the threshold test for patentability, is defined as "any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof." (11) The statute on patentable subject matter, 35 U.S.C. [section] 101, is given broad meaning through the use of the word "any" in describing the type of new and useful processes that are patentable, the legislative history surrounding its enactment, and the interpretation that "anything under the sun that is made by man" is patentable. (12) The proper forum for excluding a specific subject matter from the patent bargain lies with Congress in the legislative body and not the judiciary. (13)

However, courts recognize some subject matter as ineligible for patentability under 35 U.S.C. [section] 101. Exceptions to patentable subject matter include laws of nature, physical phenomena, and abstract ideas. (14) Products of nature should be "free to all men and reserved exclusively to none." (15) Laws of nature, physical phenomena, and abstract ideas are recognized as a type of scientific discovery, rather than a novel invention. This promotes the policy that a discovery is left to the public domain while an invention benefits from intellectual property rights. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Should Our Genes Be Part of the Patent Bargain? Maximizing Access to Medical Diagnostic Advances While Ensuring Research Remains Profitable
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.